| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/11/1994 | EP0595860A1 DNAs ENCODING PROTEINS ACTIVE IN LYMPHOCYTE-MEDIATED CYTOTOXICITY |
| 05/11/1994 | EP0595855A1 Allergenic proteins and peptides from japanese cedar pollen |
| 05/11/1994 | EP0595838A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 05/11/1994 | EP0595822A1 Thyroidal receptor for n-acetylglucosamine |
| 05/11/1994 | EP0595798A1 Bispecific heteroantibodies with dual effector functions |
| 05/11/1994 | EP0429478B1 Expression cassette for plants |
| 05/11/1994 | EP0344297B1 Treatment of cancer with somatostatin and analogs thereof |
| 05/11/1994 | DE4239026A1 Verfahren zur Erhöhung des Proteingehaltes von Pflanzen A method of increasing the protein content of plants |
| 05/11/1994 | DE4237668A1 DNA encoding aphrodisin with an N-terminal signal peptide |
| 05/11/1994 | CN1086543A CDNA clones coding for polypepstides exhibiting human granulocyte macrophage and eosinophie cellular growth |
| 05/11/1994 | CN1086437A Method for inhibiting HIV replication using IL-4 |
| 05/11/1994 | CA2448557A1 Multidrug resistance gene |
| 05/11/1994 | CA2148690A1 Purified tsh preparation, process for its production and its use for the production of tsh tracers for tsh receptor assays and in tsh receptor assays |
| 05/11/1994 | CA2148685A1 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 05/11/1994 | CA2148504A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/11/1994 | CA2148479A1 Fibronectin binding protein as well as its preparation |
| 05/11/1994 | CA2148451A1 Plants with reduced susceptibility to plant-parasitic nematodes |
| 05/11/1994 | CA2148379A1 A liquid chromatographic system |
| 05/11/1994 | CA2148274A1 Protein p53 fragments and their uses in detecting and following-up pathological conditions |
| 05/11/1994 | CA2148261A1 Anti-diarrheic product and method of treating rotavirus-associated infection |
| 05/11/1994 | CA2148258A1 Transcription factor dp-1 |
| 05/11/1994 | CA2148119A1 Interferon tau compositions and methods of use |
| 05/11/1994 | CA2148007A1 Allergenic extracts |
| 05/11/1994 | CA2147877A1 Immunization against neisseria gonorrhoeae and neisseria meningitidis |
| 05/11/1994 | CA2147769A1 Novel biologically active peptides and uses therefor |
| 05/11/1994 | CA2147756A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | CA2147754A1 Compositions and methods for modifying the regulatory activity of tgf- .beta. |
| 05/11/1994 | CA2147741A1 Low allergenic proteins |
| 05/11/1994 | CA2147617A1 Medium-chain thioesterases in plants |
| 05/11/1994 | CA2147598A1 Op-3-induced morphogenesis |
| 05/11/1994 | CA2147494A1 Intrinsic inhibitors of aldose reductase |
| 05/11/1994 | CA2147252A1 Rna packaging system |
| 05/11/1994 | CA2146926A1 Conjugate vaccine against group b streptococcus |
| 05/11/1994 | CA2146559A1 Methods of preparing soluble, oligomeric proteins |
| 05/11/1994 | CA2145546A1 Somatotropin modifications |
| 05/11/1994 | CA2143489A1 Transformed endothelial cells |
| 05/11/1994 | CA2127283A1 Urease-based vaccine against helicobacter infection |
| 05/11/1994 | CA2120131A1 Expression and purification of cloned human alpha-fetoprotein |
| 05/11/1994 | CA2088938A1 Mycoplasma probes |
| 05/10/1994 | US5310893 Oligonucleotide probe |
| 05/10/1994 | US5310892 Biagnosis for scleroderma |
| 05/10/1994 | US5310885 Process for immobilizing a protein containing substance on a solid phase |
| 05/10/1994 | US5310883 Stabilized versions of glu-3,5-basic FGF having eliminated disulfide scrambled forms; wound healing agents; promoters of angiogenesis, neutrotropism and chemotaxis |
| 05/10/1994 | US5310882 Somatotropins with alterations in the α-helix 3 region |
| 05/10/1994 | US5310881 Reaction product of mucopolysaccharides and enzymes, sustained release, drugs |
| 05/10/1994 | US5310880 Purification of Mullerian inhibiting substance |
| 05/10/1994 | US5310879 For gramnegative bacteria assay |
| 05/10/1994 | US5310878 Biosynthetic cerebrospinal fluid control and method of use |
| 05/10/1994 | US5310877 Ultrafiltration using an altered substrate microfilter impregnated with solid particles |
| 05/10/1994 | US5310876 Expression of HIV1 and HIV2 polypeptides and their use |
| 05/10/1994 | US5310874 Immunoassay |
| 05/10/1994 | US5310873 Cyclohexapeptide compound |
| 05/10/1994 | US5310740 Renin inhibitors |
| 05/10/1994 | US5310729 Interferon-related polypeptides as CR2 ligands and their use for modulating immune cell functions |
| 05/10/1994 | US5310688 Method and apparatus for eluting proteins in affinity membrane process |
| 05/10/1994 | US5310678 Genetic engineering, poultry |
| 05/10/1994 | US5310671 Vector for foreign dna and sequence for regulating thegene; vaccines |
| 05/10/1994 | US5310668 Varicella-zoster virus as a live recombinant vaccine |
| 05/10/1994 | US5310663 Affinity peptides |
| 05/10/1994 | US5310662 Receptors: their identification, characterization, preparation and use |
| 05/10/1994 | US5310661 Nucleic acid encoding the α chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| 05/10/1994 | US5310660 Method and a hybrid promoter for controlling exogenous gene transcription |
| 05/10/1994 | US5310654 Method for determining virulence of Yersinia |
| 05/10/1994 | US5310653 Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis |
| 05/10/1994 | US5310651 DNA probes of human immunodeficiency virus type 2 (HIV-2), and methods employing these probes for dectecting the presence of HIV-2 |
| 05/10/1994 | US5310550 Platelet deficiency |
| 05/10/1994 | US5310462 Quantitation of samples utilizing capillary electrophoresis |
| 05/10/1994 | CA1329446C Peptides with laminin activity |
| 05/10/1994 | CA1329445C Process for preparing n-¬1(s)-ethoxycarbonyl-3- phenylpropyl|-l-alanyl-l-proline |
| 05/10/1994 | CA1329373C Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
| 05/07/1994 | CA2102547A1 Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein |
| 05/06/1994 | CA2102463A1 Protein and gene encoding said protein |
| 05/05/1994 | DE4335366A1 Verfahren zur Herstellung eines kristallinen Typ A Botulinum Toxins als therapeutische Arznei A process for preparing a crystalline botulinum toxin type A as a therapeutic drug |
| 05/05/1994 | DE4237129A1 Application of complementary peptide(s) in oncology and cardiology - pref. using peptide(s) complementary to human papilloma virus type 16 onco-protein E7, binding to retino-blastoma proteins |
| 05/04/1994 | EP0595659A2 Extracellular matrix receptor ligands that modulate leukocyte function |
| 05/04/1994 | EP0595638A2 Epitope-related peptides of human parvovirus |
| 05/04/1994 | EP0595476A2 Dictyostelium dipeptidylaminopeptidase |
| 05/04/1994 | EP0595436A2 Porcine respiratory and reproductive disease virus, vaccines and viral DNA |
| 05/04/1994 | EP0595334A2 Mutant AOX2 promoter, vector carrying same, transformant, and production of heterologous protein |
| 05/04/1994 | EP0595188A2 Process for producing vaccine for a bacterial toxin belonging to the RTX toxin family |
| 05/04/1994 | EP0594881A1 Expression vectors and their application in the construction of HIV-resistant human cells for therapeutic uses |
| 05/04/1994 | EP0594847A1 Dna coding for human fk506-binding protein and expression thereof |
| 05/04/1994 | EP0594771A1 Nucleotide sequences and resistance proteins cycloheximide |
| 05/04/1994 | EP0594764A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
| 05/04/1994 | EP0594710A1 Tyrosine kinase |
| 05/04/1994 | EP0594669A1 NOVEL GROWTH FACTOR-RESPONSIVE PROGENITOR CELLS WHICH CAN BE PROLIFERATED $i(IN VITRO) |
| 05/04/1994 | EP0594638A1 Peptides for use in induction of t cell activation against hiv-1 |
| 05/04/1994 | EP0594631A1 Bordetella bronchiseptica outer membrane antigen |
| 05/04/1994 | EP0594613A1 Synthetic peptides of human papillomaviruses 1, 6, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes |
| 05/04/1994 | EP0594610A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
| 05/04/1994 | EP0594586A1 Hiv protease inhibitors |
| 05/04/1994 | EP0516655B1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine |
| 05/04/1994 | EP0514413B1 Immunologically active peptides or polypeptides from the parvovirus b19 |
| 05/04/1994 | EP0439601B1 Composition containing a b epitope of the envelope glycoprotein of a retrovirus and a t epitope of a distinct protein from this virus |
| 05/04/1994 | EP0413695B1 Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3. |
| 05/04/1994 | EP0229046B1 Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique |
| 05/04/1994 | EP0148843B2 A concentrate of the antihemophilic factor viii and a process for producing it |
| 05/04/1994 | CN1086264A Method for preparing antigenic protein capable of testing C-type hepatitis by using colibacillus |
| 05/04/1994 | CN1086221A Peptide compounds |